Halozyme Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$64.12

-1.07 (-1.64%)

As of May 9, 1:11 AM ET ·

Next Earnings Report

May 12, 2026

Time TBD

2 days away

EPS Estimate $1.56

Revenue Est $366.23M

Earnings History

Date	Quarter	EPS Est	EPS Actual	Surprise	Surprise %	Result
Feb 24, 2026	Q1 FY2026	$2.24	—	—	—	—